Liquidia proclaimed positive Phase1 and Preclinical results for LIQ861 for treatment of PAH Read more
COMPASS Trial results advocate Penumbra’s Frontline Thrombectomy approach for Acute Ischemic Stroke Read more
FDA concedes SOBI’s IND application for SOBI003 along with Fast Track Status for treating MPS IIIA Read more
CHMP of EMA conveyed negative trend vote of Puma’s MA for neratinib for treating HER2-positive Breast Cancer Read more
Cerus affirms positive results for Phase 3 transfusion study assessing INTERCEPT RBC’s in Thalassemia patients Read more